Aptevo Therapeutics Inc (APVO)

Aptevo Therapeutics Inc (APVO) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $3.1M; returns 1 day +0.0%, 1 week -0.6%, 1 year -94.2%.

Aptevo Therapeutics Inc. is a clinical-stage biotechnology company focused on developing novel immunotherapies for oncology and autoimmune diseases. They utilize their proprietary ADAPTIR and ADAPTIR-FLEX platforms to develop bispecific and trispecific antibody candidates that enhance the human immune system against cancer cells.

Groups APVO belongs to

• Biotechnology
• Recent Reverse Splits
• Clinical Stage Biotech
• Oncology
• Immunotherapy
• Bispecific Antibodies
• Healthcare
• Antibody Therapeutics
• Cancer Therapeutics
• Clinical Stage
• Autoimmune Diseases
• Life Sciences

APVO financial model: income statement, cash flow and balance sheet